Bio-Thera Solutions Ltd (SHG:688177) — Market Cap & Net Worth
Market Cap & Net Worth: Bio-Thera Solutions Ltd (688177)
Bio-Thera Solutions Ltd (SHG:688177) has a market capitalization of $1.03 Billion (CN¥7.06 Billion) as of June 23, 2026. Listed on the SHG stock exchange, this China-based company holds position #8927 globally and #2249 in its home market, demonstrating a 1.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-Thera Solutions Ltd's stock price CN¥17.06 by its total outstanding shares 414080000 (414.08 Million). Review Bio-Thera Solutions Ltd debt and liabilities to assess the company's total debt and financial obligations.
Bio-Thera Solutions Ltd Market Cap History: 2020 to 2026
Bio-Thera Solutions Ltd's market capitalization history from 2020 to 2026. Data shows change from $1.93 Billion to $1.03 Billion (-18.07% CAGR).
Bio-Thera Solutions Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-Thera Solutions Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.50x
Bio-Thera Solutions Ltd's market cap is 1.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.93 Billion | $184.99 Million | -$513.23 Million | 10.42x | N/A |
| 2021 | $1.57 Billion | $836.58 Million | $81.94 Million | 1.87x | 19.10x |
| 2022 | $1.32 Billion | $455.13 Million | -$480.40 Million | 2.90x | N/A |
| 2023 | $2.50 Billion | $704.79 Million | -$394.53 Million | 3.55x | N/A |
| 2024 | $1.17 Billion | $743.17 Million | -$510.30 Million | 1.58x | N/A |
| 2025 | $1.40 Billion | $935.22 Million | -$331.94 Million | 1.50x | N/A |
Competitor Companies of 688177 by Market Capitalization
Companies near Bio-Thera Solutions Ltd in the global market cap rankings as of June 23, 2026.
Key companies related to Bio-Thera Solutions Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #571 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.70 |
| #571 | Argen-X | BR:ARGX | $47.14 Billion | €773.80 |
Bio-Thera Solutions Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, Bio-Thera Solutions Ltd's market cap moved from $1.93 Billion to $ 1.03 Billion, with a yearly change of -18.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.03 Billion | -26.27% |
| 2025 | CN¥1.40 Billion | +19.40% |
| 2024 | CN¥1.17 Billion | -53.01% |
| 2023 | CN¥2.50 Billion | +89.35% |
| 2022 | CN¥1.32 Billion | -15.68% |
| 2021 | CN¥1.57 Billion | -18.77% |
| 2020 | CN¥1.93 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Bio-Thera Solutions Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.03 Billion USD |
| MoneyControl | $1.03 Billion USD |
| MarketWatch | $1.03 Billion USD |
| marketcap.company | $1.03 Billion USD |
| Reuters | $1.03 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bio-Thera Solutions Ltd
Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. It offers QLETLI for the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, and uveitis; POBEVCY to treat patients with metast… Read more